The medical injection molding industry sees a rapid pace of technological innovation, with global enterprises vying for efficient and clean solutions.

As the global demand for medical devices continues to rise, medical injection molding, as a core manufacturing process, is entering a critical phase of technological innovation and service upgrades. Recently, both domestic and international companies have launched high-precision, high-purity injection molding equipment and solutions, ranging from liquid silicone rubber (LSR) molding to the production of miniature medical devices. From establishing localized service networks to global supply chain layouts, the industry is rapidly advancing towards "more efficient, more precise, and more green" directions, providing solid support for the innovation of the medical device industry.

In the high-end equipment sector, German company Arburg's technological breakthroughs stand out. Its new TREND series of electric injection molding machines, positioned as "entry-level high-end," demonstrates strong performance in medical consumables production. For instance, the TREND 1800 e model with a 200-ton clamping force, when paired with molds provided by Austrian ACH, can produce 64-cavity liquid silicone medical consumables. The cavity system design achieves clean molding with no flash or gates. Additionally, the fully electric drive system significantly reduces energy consumption and maintenance costs, while high injection speed and dynamic adjustment features further enhance product yield. Moreover, Arburg equips this model with a complete LSR production configuration, including silicone process software package, patented anti-reverse valve barrel package, and independent cooling water drain, to meet the manufacturing needs of high-precision medical products. It has become the preferred equipment for many medical companies to upgrade their production lines.

Domestic enterprises are also making strides in niche markets. Yizumi's customized solutions for the overseas market have garnered significant attention. The equipment employs a contactless tiebar (TBF) technology, preventing lubricant contamination during the clamping process. It also optimizes the plasticizing components, boosting the plasticizing efficiency by over 20%, perfectly meeting the dual requirements of cleanliness and efficiency in the medical industry. To deepen its presence in the Indonesian market, Yizumi has accelerated the establishment of a localized service network, having already set up service centers in Semarang and is advancing the construction of a new one in Surakarta. In the future, it aims to cover the main industrial clusters on Java Island, providing local medical manufacturing companies with timely technical support and equipment guarantees.

The micro-medical device manufacturing sector has achieved a new breakthrough with the launch of WITTMANN's MicroPower 15 micro-injection molding machine, which has garnered widespread attention at CHINAPLAS 2025. This machine is capable of producing biodegradable medical surgical clamps weighing just 0.9mg, achieving 8-hole simultaneous molding through a single female mold and double male mold design, with weight tolerance controlled within ±0.001mg for ultra-high precision. The production cycle is shortened to 6.8 seconds, and with the integration of an automated robotic arm and optical inspection system, it achieves full-process unmanned operation from injection to sorting, boosting efficiency by 60% compared to traditional equipment, achieving a 100% yield rate. It provides a new solution for the production of micro-components in the fields of minimally invasive medical devices and diagnostic reagents.

Viewing market trends, the global medical injection molding industry is steadily expanding. According to relevant data, the global medical injection molding market reached $2.574 billion in 2025 and is expected to grow to $3.898 billion by 2032 at a compound annual growth rate of 6.12%. This growth is driven by the increasing demand for medical devices, as well as the continuous empowerment of technological innovation – the application of micro-injection molding, multi-component molding, and intelligent monitoring technologies, constantly broadening the scope of medical injection molding from conventional consumables like catheters to high-end products such as implantable devices and diagnostic chips. The industry is gradually covering more niche areas within the healthcare sector.

The medical injection molding industry has now formed a development pattern of "global technology collaboration and regional service focus." International companies are capturing the high-end market with their technical accumulation, while domestic enterprises are rapidly rising through localized services and cost advantages. Both are driving the upgrading of industry standards. In the future, with the advancement of material technology and the increased environmental protection requirements, medical injection molding will further break through towards "low energy consumption, biodegradable, and high integration," injecting more momentum into the global development of the healthcare industry.